New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 19, 2014
13:39 EDTIARTIntegra LifeSciences deal could drive revenue growth, says Argus
Argus believes that Integra’s new three-year agreement with Premier , announced on June 12, could significantly increase the company's revenue growth in the future. The firm finds the stock's valuation attractive and keeps a Buy rating on the shares.
News For IART From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 26, 2015
07:18 EDTIARTIntegra DFU study results positive in aggregate, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien stated after Integra LifeSciences' DFU data was published that some competitive products have better metrics in certain areas. However, all told, O'Brien views the results positively and expects Integra to have one of the best wound care portfolios in the market once this product is cleared and reimbursed sometime next year, he tells investors in a research note. The analyst kept an Overweight rating and $72 price target on Integra shares, which closed up 39c to $59.25 yesterday.
07:13 EDTIARTIntegra LifeSciences announces online publication of FOUNDER study results
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use